| Serial Number | 99436273 |
| Word Mark | OPTIMISM |
| Filing Date | Friday, October 10, 2025 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Wednesday, March 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals that treat systemic mastocytosis |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Telios Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Redwood City, CA 94065 US |
| Event Date | Event Description |
| Friday, October 10, 2025 | NEW APPLICATION ENTERED |
| Friday, October 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 15, 2025 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, October 15, 2025 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Friday, February 27, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, March 4, 2026 | SUSPENSION LETTER WRITTEN |
| Wednesday, March 4, 2026 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, March 4, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |